XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Balance at beginning of period (in shares) at Dec. 25, 2020   59,217,000        
Balance at beginning of period at Dec. 25, 2020 $ 617,739 $ 592 $ 659,093 $ (43,018) $ 756 $ 316
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (36,457)     (36,402)   (55)
Foreign currency translation adjustments (784)       (784)  
Equity contributions 10,025   10,025      
Equity-based compensation 21,522   21,522      
Issuance of common stock for initial public offering, net of offering costs (in shares)   15,021,000        
Issuance of common stock for initial public offering, net of offering costs 249,154 $ 150 249,004      
Issuance of common stock pursuant to equity incentive plans (in shares)   189,000        
Issuance of common stock pursuant to equity incentive plans 0 $ 2 (2)      
Establishment of income tax receivable liability (112,681)   (112,681)      
Other (243)   (243)      
Balance at end of period (in shares) at Dec. 31, 2021   74,427,000        
Balance at end of period at Dec. 31, 2021 748,275 $ 744 826,718 (79,420) (28) 261
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (8,675)     (8,626)   (49)
Foreign currency translation adjustments (4,208)       (4,208)  
Equity-based compensation 22,853   22,853      
Repurchase and retirement of common stock (in shares)   (269,000)        
Repurchase and retirement of common stock (2,887) $ (3) (2,884)      
Issuance of common stock pursuant to equity incentive plans (in shares)   620,000        
Issuance of common stock pursuant to equity incentive plans 0 $ 6 (6)      
Issuance of common stock pursuant to employee stock purchase plan (in shares)   158,000        
Issuance of common stock pursuant to employee stock purchase plan 1,509 $ 2 1,507      
Parasol equity acquisition (in shares)   106,000        
Parasol equity acquisition $ 304 $ 1 515     (212)
Balance at end of period (in shares) at Dec. 30, 2022 75,042,000 75,042,000        
Balance at end of period at Dec. 30, 2022 $ 757,171 $ 750 848,703 (88,046) (4,236) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (21,368)     (21,368)    
Foreign currency translation adjustments 683       683  
Equity-based compensation 22,741   22,741      
Repurchase and retirement of common stock (in shares)   (27,000)        
Repurchase and retirement of common stock (238)   (238)      
Issuance of common stock pursuant to equity incentive plans (in shares)   762,000        
Issuance of common stock pursuant to equity incentive plans 0 $ 8 (8)      
Issuance of common stock pursuant to employee stock purchase plan (in shares)   322,000        
Issuance of common stock pursuant to employee stock purchase plan 2,842 $ 3 2,839      
Tax withholding on net share settlement of equity awards (in shares)   (155,000)        
Tax withholding on net share settlement of equity awards (1,578) $ (2) (1,576)      
TRA distribution to shareholders $ (396)   (396)      
Balance at end of period (in shares) at Dec. 29, 2023 75,944,000 75,944,000        
Balance at end of period at Dec. 29, 2023 $ 759,857 $ 759 $ 872,065 $ (109,414) $ (3,553) $ 0